Atev 10 mg (Ezetimibe)
Ezetimibe 10mg
Tablet · Prescription medication
Poongrim Pharmaceutical Co., Ltd.
MFDS item code 201902771 · Approved 2019.04.30
This product's status changed to Approval withdrawn on 2023.09.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hypercholesterolemia, sitosterolemia, and mixed hyperlipidemia
This medication is used as an adjunct to dietary therapy to lower total cholesterol, LDL cholesterol, and apolipoprotein B levels in patients with primary hypercholesterolemia and mixed hyperlipidemia. It also helps reduce blood cholesterol levels when used alone or in combination with other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. It is also used to reduce blood sitosterol levels in patients with homozygous sitosterolemia, alongside diet. This medication is used in conjunction with an appropriate diet and is administered when improvements are difficult through other non-pharmacological measures. It is important to identify and treat secondary causes of the condition before administration and to base the treatment plan on lipid test results. Overall, this medication is used to manage blood lipid levels related to hyperlipidemia, improving vascular health.
Continue a standard cholesterol-lowering diet during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, with or without food. When this medicine is coadministered with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), start coadministration with this medicine at the recommended initial dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, coadminister this medicine while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is coadministered with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). 1. Administration in patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). 2. Administration in patients with renal impairment No dose adjustment is required in patients with renal impairment. 3. Administration in older adults No dose adjustment is required when administering this medicine to older adults. 4. Concomitant administration with bile acid sequestrants Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Drug Interactions).
This medication should not be used in patients who are allergic to any of its components. Patients with severe liver impairment or persistently elevated liver enzyme levels of unknown cause should not take this medication in conjunction with certain lipid-lowering agents. Pregnant or breastfeeding women should be careful, as the concurrent use of this medication with certain lipid-lowering agents is prohibited. Patients with moderate to severe liver impairment should be cautious as unexpected side effects may occur when taking this medication. During treatment with this medication, symptoms such as headache, abdominal pain, diarrhea, fatigue, and muscle pain may appear; if these abnormal symptoms persist, consult a doctor. If muscle pain or weakness occurs suddenly, inform a physician immediately, and in severe cases, the medication may need to be discontinued. This medication can increase liver enzyme levels, so regular liver function tests are important. Patients with severe renal impairment should also exercise caution when taking the medication and may need to adjust doses according to a doctor’s instructions. There may be interactions with other medications, so it is essential to inform healthcare providers of any medications being taken. Children, pregnant women, and elderly patients require special attention, and it is not recommended for children under 6 years of age. In the case of overdose, seek medical attention immediately for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent moisture ingress and at a temperature between 1 to 30 degrees Celsius for safety. Storing it this way will help maintain the medication's effectiveness.
White to almost white oblong tablets
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ezetimibe 10mg
Tablet · Prescription medication
Poongrim Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Shin Il Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.